Quick Answer
Celldex Therapeutics, Inc. reported Shares Outstanding of 66.55 million shares for fiscal year 2025.
Celldex Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 66.55M | +0.3% |
| 2024 | 66.37M | +18.8% |
| 2023 | 55.88M | +18.4% |
| 2022 | 47.20M | +1.0% |
| 2021 | 46.73M | +18.0% |
| 2020 | 39.60M | +133.3% |
| 2019 | 16.97M | +41.9% |
| 2018 | 11.96M | +29.5% |
| 2017 | 9.23M | -92.3% |
| 2016 | 120.52M | +22.1% |
| 2015 | 98.69M | +10.1% |
| 2014 | 89.59M | +0.4% |
| 2013 | 89.25M | +38.7% |
| 2012 | 64.36M | +45.6% |
| 2011 | 44.21M | +37.9% |
| 2010 | 32.06M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 66.45M | +0.2% | +0.1% |
| June 30, 2025 | 66.39M | +0.2% | +0.0% |
| March 31, 2025 | 66.38M | +0.7% | +0.0% |
| December 31, 2024 | 66.37M | +18.8% | +0.0% |
| September 30, 2024 | 66.34M | +40.4% | +0.1% |
| June 30, 2024 | 66.28M | +40.3% | +0.6% |
| March 31, 2024 | 65.91M | +39.5% | +17.9% |
| December 31, 2023 | 55.88M | +18.4% | +18.2% |
- Celldex Therapeutics, Inc. showed an increase of +0.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Celldex Therapeutics, Inc.’s shares outstanding has grown by 107.6% (from 32.06 million shares to 66.55 million shares).
- The most recent figure is from Celldex Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: